The National Research and Innovation Agency (BRIN) has developed a virus-like particle (VLP) using the silkworm genetic expression system as one of the .
Seven out of the 14 vaccine antigens used for the routine immunization program in Indonesia can already be produced domestically, Minister of Health Budi .